The trajectory of Sildenafil presents a nuanced case for investors in the drug sector. While initially a tremendous success, generating billions, the intellectual property lapse and the subsequent arrival of off-brand https://gambling082708.techionblog.com/42004386/the-little-copyright-and-big-pharma-a-risky-bet